Cancer medicines
Ixazomib
Ixazomib
An oral proteasome inhibitor for myeloma.
Sources checked · Introductory guide
On this page
How it works
It blocks proteasome protein processing to promote cancer cell death.[3]
Where it is used
Combined with lenalidomide and dexamethasone in selected previously treated multiple myeloma.[1]
Key safety points
Monitor low platelets, neuropathy and digestive symptoms. Confirm dosing days and food instructions; report bleeding, severe numbness or jaundice immediately.[2]
Questions for your care team
- How do I distinguish the three medicines’ dosing, breaks and test schedules?
Sources and scope
Source documents are in English.
Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.
- NCI · Ixazomib Citrate (opens in a new tab)
- MedlinePlus · Ixazomib Citrate (opens in a new tab)
- NCI Drug Dictionary · Ixazomib Citrate (opens in a new tab)
General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.